Literature DB >> 9686625

Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients.

J Van Weyenbergh1, P Lipinski, A Abadie, D Chabas, U Blank, R Liblau, J Wietzerbin.   

Abstract

Monocyte-macrophage activation by IFN-gamma is characterized by a pronounced increase of high affinity Fc receptors for IgG (Fc gamma RI), capable of triggering respiratory burst, phagocytosis, Ab-dependent cytotoxicity, and release of proinflammatory cytokines. In view of the antagonism of IFN-beta on IFN-gamma action, of interest in the chronic inflammatory disorder multiple sclerosis, we examined the possible effect of IFN-beta on IFN-gamma induction of Fc gamma RI gene expression. We found that IFN-beta significantly down-regulated IFN-gamma-induced Fc gamma RI surface expression in peripheral blood monocytes from healthy donors, in a dose- and time-dependent manner. This down-regulation of Fc gamma RI surface levels did not correspond to a decrease in Fc gamma RI mRNA, suggesting a posttranscriptional effect of IFN-beta. Down-regulation of Fc gamma RI surface expression correlated with diminished cellular signaling through Fc gamma RI, since the IFN-gamma-induced increase in Fc gamma receptor-triggered respiratory burst was nearly completely abrogated by simultaneous addition of IFN-beta. Finally, the same antagonism between both IFNs on Fc gamma RI surface expression was observed in peripheral blood monocytes derived from multiple sclerosis patients; inhibition by IFN-beta was even increased (82+/-11%), as compared with healthy controls (67+/-4%). These results may partially help explain the beneficial effect of IFN-beta in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Therapeutic strategies in multiple sclerosis. I. Immunotherapy.

Authors:  R Hohlfeld
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  Immune complex-FcgammaR interaction modulates monocyte/macrophage molecules involved in inflammation and immune response.

Authors:  P Barrionuevo; M Beigier-Bompadre; G C Fernandez; S Gomez; M F Alves-Rosa; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.

Authors:  Roma Pahwa; Uma Kumar; Nibhriti Das
Journal:  Mol Cell Biochem       Date:  2016-02-23       Impact factor: 3.396

4.  N-formyl-methionyl-leucyl-phenylalanine inhibits both gamma interferon- and interleukin-10-induced expression of FcgammaRI on human monocytes.

Authors:  M Beigier-Bompadre; P Barrionuevo; F Alves-Rosa; C J Rubel; M S Palermo; M A Isturiz
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

5.  Immune complexes (IC) down-regulate the basal and interferon-gamma-induced expression of MHC class II on human monocytes.

Authors:  P Barrionuevo; M Beigier-Bompadre; S De La Barrera; M F Alves-Rosa; G Fernandez; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia.

Authors:  Xianyuan Song; Scott Shapiro; David L Goldman; Arturo Casadevall; Matthew Scharff; Sunhee C Lee
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  IFNs Reset the Differential Capacity of Human Monocyte Subsets to Produce IL-12 in Response to Microbial Stimulation.

Authors:  Alice Muglia Amancio; Lara Mittereder; Alexie Carletti; Kevin W Tosh; Daniel Green; Lis R Antonelli; Ricardo T Gazzinelli; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2021-02-24       Impact factor: 5.422

8.  Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.

Authors:  Britta Moens; Christophe Pannecouque; Giovanni López; Michael Talledo; Eduardo Gotuzzo; Ricardo Khouri; Achiléa Bittencourt; Lourdes Farré; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  Virol J       Date:  2012-08-23       Impact factor: 4.099

9.  CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Authors:  Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Roland Liblau; Johan Van Weyenbergh
Journal:  J Neuroinflammation       Date:  2014-01-29       Impact factor: 8.322

10.  Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS.

Authors:  Jorge Gutierrez-Merino; Beatriz Isla; Theo Combes; Fernando Martinez-Estrada; Carlos Maluquer De Motes
Journal:  Gut Microbes       Date:  2020-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.